Get Free Access
TZ Ref No.: TZ-1017959
Contract Award Awarded Contract 🌍 International (ICB) Poland Pharmaceuticals Healthcare and Medicine Chemicals

Delivery of medicinal products for drug programs for patients of the Specialist Hospital in Zabrze Sp. z o. o. Case No. DZP/09 PN/2026. Package No. 25 Evolocumab B 101

Doc ref no. 00621651-2026
Sector Pharmaceuticals, Healthcare and Medicine, Chemicals
Contract Date 10 Sep 2026
Contract Value Undisclosed
Contract Intelligence
AI opportunity notes and scope analysis for this contract award

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

Sign in to unlock Bid Fit & AI Opportunity Intelligence

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Contract Description

Delivery of medicinal products for drug programs for patients of the Specialist Hospital in Zabrze Sp. z o. o. Case No. DZP/09 PN/2026. Package No. 25 Evolocumab B 101
Package No. 25 Evolocumab B 101. A detailed description of the subject of the order is Appendix No. 3 to the SWZ - Assortment and price form. In accordance with Chapter III point 3.SWZ: Subject conditions required from Contractors - Contractors submitting an offer in the procedure declare that they undertake to comply with the following requirements: 1) They will offer medicinal products that meet the requirements specified in the Act of September 6, 2001 Pharmaceutical Law (Journal of Laws 2026.612, consolidated text of 2026/05/07), consistent with the description of the subject of the order contained in the Forms. assortment and prices constituting Annex No. 3 to the SWZ. 2) The Contractor has documents confirming that the products listed in the Assortment and Price Forms constituting Annex No. 3 to the SWZ are registered with the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in accordance with the requirements of the Act of September 6, 2001. Pharmaceutical Law (Journal of Laws 2026.612, consolidated text of May 2026). 3) For medicines in all packages 1-30, the Ordering Party requires a valid GIF permit to trade in medicinal products. 4) Packages 1-30 contain biological drugs for drug programs. The Ordering Party requires that the drugs be approved for use and reimbursed in drug programs. Currently they are: 03.0000.331.02 (B31) Treatment of pulmonary arterial hypertension 03.0000.347.02 (B47) Treatment of moderate and severe plaque psoriasis 03.0000.407.02 (B 107) Treatment of chronic spontaneous urticaria 03.0000.556.02 (B156) Treatment of patients with rhinosinusitis with polyps 03.0000.424.02 (B.124) Treatment of patients with severe atopic dermatitis 03.0000.374.02 (B74) Treatment of chronic thromboembolic pulmonary hypertension (CTEPH) 03.0000.401.02 (B 101) Treatment of familial hypercholesterolemia The Ordering Party also requires that: A. The entire range consists of medicinal products B. The Contractor will sign annexes to the contracts if the reimbursement during the period of the contract is changed to products (with the same international name) that will be covered by such a refund. C. The price of the drug in the case of a drug covered by the official price during the entire duration of the contract must be consistent with the current official price of the given drug on the day of the order execution, in the event of a change in the rules for financing the purchase of drugs by the National Health Fund, lowering prices or lowering the official price of the drug below the price resulting from the offer, the Contractors will sign an annex for the duration of their validity, after this period the price will return to the price resulting from the original tender offer of the Contractor, which is always the maximum price for the Ordering Party. D. The product will be transported to the place indicated by the Ordering Party in accordance with the requirements set out in the CHPL for medicinal products. E. The Contractor will provide the Summary of Product Characteristics (ChPL) or its equivalent translation into Polish (PACKAGES 1-30) with the offer. 5) The Contractor will ensure, at its own expense and risk, the transport of medicinal products to the place indicated by the Ordering Party. The transport of all medicinal products will take place in accordance with the requirements provided for in the current documents confirming the authorization of the subject of the order for trading and use in accordance with the Act of September 6, 2001 Pharmaceutical Law (Journal of Laws 2026.612, i.e. of May 2026) and the Regulation of the Minister of Health of October 22, 2022. on the basic conditions for running a pharmacy (Journal of Laws 2025.1579) as amended by the Regulation of the Minister of Health of November 17, 2025 amending the regulation on the basic conditions for running a pharmacy. The ordering party has the right to inspect the means of transport in which medicinal products are transported for the presence of records of the temperature in the transport chamber and the presence of platforms on which boxes of medicinal products are transported. In the event of failure to meet the transport requirements provided for in the current documents confirming the admission of the subject of the order to trading, provided for in the Act of September 6, 2001, Pharmaceutical Law (Journal of Laws 2026.612, i.e. of May 2026, 2007), the Ordering Party has the right to refuse their receipt and inform the Contractor about the fact. The Contractor provides transport adapted to the Ordering Partys infrastructure. All medicinal products will be transported using appropriate means of transport, ensuring the maintenance of the correct temperature for the transported medicinal products and medical devices, with the possibility of heating or cooling the transported goods and compliance with GMP rules, if applicable. 6) Offer products with an expiry date of at least 12 months from the date of delivery. 7) During the term of the contract, the Ordering Party has the right to request the Contractor to present current marketing authorization documents, safety data sheets, leaflets - in Polish. 8) They will offer a payment term of 30 days from the date of deliveryThe ordering party receives a correctly issued VAT invoice. 9) They will sign the contract, the template of which is attached as Annex 4 to the SWZ. 10) They will offer a maximum processing time for cito orders: 24 hours, and in normal mode up to 48 hours from placing the order, regardless of the value of the order placed. a) In the case of on-call deliveries, if the delivery date falls on a Saturday or another public holiday or outside the Ordering Partys working hours, the delivery will take place within the agreed delivery time, i.e. a maximum of 24 hours from placing the order to the place indicated by the Ordering Party. b) In the case of orders in normal mode, the deadline for which falls on a Saturday or a public holiday, the deadline expires on the first business day after the deadline specified above, but no later than 11.00 a.m. on that day.

Days to Deadline
52 days
Closing: 09 Dec 2026, 00:00

Consortium & JV Partners

Matched
Need a Co-Bidder or Subcontractor?

Forming a Joint Venture increases technical eligibility and financial bonding capacity.

Post / Find JV Partners →

Key Contract Details

Doc ref no. 00621651-2026
Notice Type Contract Award
Contract CPV 38116000, 38000000, 24521400
Contract Project Location Poland
Contract Value Undisclosed
Contract Date 10 Sep 2026
Contract Deadline 09 Dec 2026

Buyer Contact Information

Contact Details Locked

Nodal officer email, telephone, and website coordinates are unlocked upon free sign up.

Unlock Contact Details (Free) →